Search Results - "Agha, M. E."

Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones by Riddell, Stanley R., Watanabe, Kathe S., Goodrich, James M., Li, Cheng R., Agha, Mounzer E., Greenberg, Philip D.

“…The adoptive transfer of antigen-specific T cells to establish immunity is an effective therapy for viral infections and tumors in animal models. The…”
Get full text

S185: CARTITUDE‐2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY by Agha, M. E., Donk, N. W., Cohen, A. D., Cohen, Y. C., Anguille, S., Kerre, T., Roeloffzen, W., Schecter, J. M., De Braganca, K. C., Varsos, H., Mistry, P., Roccia, T., Zudaire, E., Corsale, C., Akram, M., Geng, D., Nesheiwat, T, Pacaud, L., Sonneveld, P., Zweegman, S.

Get full text

EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER 1–3 PRIOR LINES OF THERAPY: CARTITUDE-2 PHASE 2 STUDY by ME Agha, AD Cohen, D Madduri, YC Cohen, M Delforge, J Hillengass, H Goldschmidt, K Weisel, M Raab, C Scheid, JM Schecter, KC Braganca, H Varsos, L Wang, M Vogel, MJ Carrasco-Alfonso, M Akram, X Wu, T Nesheiwat, H Einsele

“…Objectives: Cilta-cel is a CAR-T cell therapy that expresses 2 BCMA-targeting single-domain antibodies, designed to confer avidity. In the multicohort, phase 2…”
Get full text

Investigation of Rheological and Geometric Properties Effect on Nonlinear Behaviour of Fluid Viscous Dampers by Bouayad Agha, M A, Ras, A A, Hamdaoui, K

“…Global approval of the use of fluid viscous dampers to control the buildings response against dynamic loadings is growing. The idea behind incorporating…”
Get full text

Should autologous or allogeneic stem-cell therapy be a part of consolidation therapy for all cases of adult acute myelogenous leukemia? by Garcia-Manero, G, Schuster, S J, Agha, M E

Get more information

SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen by Bikel, I, Montano, X, Agha, M E, Brown, M, McCormack, M, Boltax, J, Livingston, D M

“…A murine recombinant Neo(r) retrovirus encoding the SV40 small t antigen was used to infect Balb/c 3T3 CIA31 cells. From analyses of G418-resistant clones…”
Get more information

Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients by Fukuta, Yuriko, MD, Muder, Robert R., MD, Agha, Mounzer E., MD, Clarke, Lloyd G., BS, Wagener, Marilyn M., MPH, Hensler, Amelia M., BS, Doi, Yohei, MD, PhD

“…Background Data regarding multidrug-resistant (MDR) Acinetobacter baumannii infections among cancer patients are limited. Methods We conducted a case-control…”
Get full text

Subretinal microsurgery with gradient index endoscopes by Koch, F H, Luloh, K P, Augustin, A J, el Agha, M S, Guembel, H, Ohrloff, C, Grizzard, W S, Hammer, M E, Sinclair, S

“…State-of-the-art subretinal surgery involves a standard three-port pars plana entry, followed by an iatrogenic retinotomy to access the subretinal space…”
Get more information